Your browser doesn't support javascript.
loading
Lipid Lowering in "Very High Risk" Patients Undergoing Coronary Artery Bypass Surgery and Its Projected Reduction in Risk for Recurrent Vascular Events: A Monte Carlo Stepwise Simulation Approach.
Deo, Salil; Ueda, Peter; Sheikh, Adil Muhammad; Altarabsheh, Salah; Elgudin, Yakov; Rubelowsky, Joseph; Cmolik, Brian; Hawkins, Neil; McAllister, David; Ruel, Marc; Sattar, Naveed; Pell, Jill.
Afiliação
  • Deo S; Institute of Health and Wellbeing, University of Glasgow, Glasgow, United Kingdom.
  • Ueda P; Louis Stokes Cleveland VA Medical Center, Cleveland, OH.
  • Sheikh AM; Case School of Medicine, Case Western Reserve University, Cleveland, OH.
  • Altarabsheh S; Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Solna, Sweden.
  • Elgudin Y; Department of Cardiology, Southern Illinois University School of Medicine, Springfield, IL.
  • Rubelowsky J; Department of Cardiac Surgery, Queen Alia Heart Institute, Amman, Jordan.
  • Cmolik B; Louis Stokes Cleveland VA Medical Center, Cleveland, OH.
  • Hawkins N; Case School of Medicine, Case Western Reserve University, Cleveland, OH.
  • McAllister D; Louis Stokes Cleveland VA Medical Center, Cleveland, OH.
  • Ruel M; Case School of Medicine, Case Western Reserve University, Cleveland, OH.
  • Sattar N; Louis Stokes Cleveland VA Medical Center, Cleveland, OH.
  • Pell J; Case School of Medicine, Case Western Reserve University, Cleveland, OH.
J Cardiovasc Pharmacol ; 81(2): 120-128, 2023 02 01.
Article em En | MEDLINE | ID: mdl-36315474

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Hidroximetilglutaril-CoA Redutases / Anticolesterolemiantes Tipo de estudo: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Cardiovasc Pharmacol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Hidroximetilglutaril-CoA Redutases / Anticolesterolemiantes Tipo de estudo: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Cardiovasc Pharmacol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido